Without a specific news headline driving the move, DexCom (DXCM) sits at a recent close of US$70.69, leaving investors weighing its continuous glucose monitoring business against recent share price ...

In the preceding three months, 12 analysts have released ratings for DexCom (NASDAQ:DXCM), presenting a wide array of ...

BTIG analysts continue to expect growth from Dexcom (Nasdaq:DXCM) after meeting with the company's senior investor relations (IR) officials.

DexCom has underperformed the Nasdaq Composite over the past year, yet analysts remain highly optimistic about the stock’s ...

Intuitive Surgical, the leader in the robotic-assisted surgery (RAS) market, encountered at least two obstacles in 2025. First, tariffs took a bite out of the company's financial results. Second, ...

We recently published an article titled 13 Best Internet of Things (IoT) Stocks to Buy Now. On February 13, Mizuho analyst ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

One underappreciated reason why I feel DXCM could potentially gain more favorable interest is because its long-suffering ...

Dexcom will stop producing G6 CGM sensors July 1, 2026, urging patients to switch to the smaller, more accurate G7 model.

DexCom (NASDAQ: DXCM) has outperformed the market over the past 10 years by 2.92% on an annualized basis producing an average annual return of 16.14%. Currently, DexCom has a market capitalization of ...

Let's consider why this healthcare specialist could be an under-the-radar winner of the GLP-1 boom. Will AI create the world's first trillionaire? Our team just released a report on the one ...

DexCom, Inc. (NASDAQ:DXCM) is one of the 10 best healthcare equipment stocks to buy according to hedge funds. On February 13, William Plovanic from Canaccord Genuity reduced the price target on DexCom ...